Stephen Mayo - 05 Jun 2024 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALLO	Stock Option (Right to buy)	Award	$0	+191,082		$0.000000	191,082	05 Jun 2024	Common Stock	191,082	$2.44	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Vesting in 12 equal monthly installments